Expert Pitch

In new normal, hotels to compete on ‘sanitized cleanliness’

Cornell University
4-May-2020 12:05 PM EDT, by Cornell University

As businesses countrywide start to reopen, industries are struggling to come up with safety standards to reassure consumers. Within the hospitality sector, the American Hotel & Lodging Association recently released their recommendations, the Safe Stay initiative, for how hotels can enhance their safety protocols in COVID-19 times.

Kate Walsh, dean of Cornell University’s School of Hotel Administration, is an expert on hospitality management. She says that sanitized cleanliness will be the new differentiator within the industry.

Bio: https://sha.cornell.edu/faculty-research/faculty/kmw33/

Walsh says: “The hospitality industry is facing an unprecedented time, as it redefines what service means going forward. The key to bringing guests back will be to convey that the hotel is safe and secure, and that guests’ health and well-being are paramount. This means that, as they plan to re-open, hotels must be laser-focused on building consumer-confidence that it is safe to stay at their property. This will become the new brand promise.

“The post-COVID traveler can expect social distancing in the open areas of the hotel, a deeply sanitized room, amenities that include face masks and hand sanitizer, and where possible, accessing the room from a guest’s mobile device. Sanitized cleanliness will be the new differentiator. Hotels have always focused on personalized service and providing a warm, welcoming environment for guests. The challenge for hotels will be to convey the essence of hospitality when we socially distance and disconnect guests from the staff. The entire business model and value proposition will need to be reexamined. However, this is also an opportunity to rethink what service truly means in this new normal.

“How do you work with reduced density? As the hospitality industry plans for its re-opening and return of its staff, one of the biggest issues will be re-training staff on new ways of working, especially to visibly demonstrate to guests that the hotel is being continuously sanitized. Staff are going to be asked to be agile and flexible, and new hospital-grade sanitation technology will be in demand.”

For other angles on the hospitality industry, please consider the experts below:

• Chekitan Dev is professor of marketing and an expert in hospitality branding. His study of the hotel business during the 2008 recession offers useful comparisons to what the industry is experiencing now. • Alex Susskind is professor of food and beverage management and can speak to the strategic thinking needed to deal with the immediate and long-term effects of the coronavirus on the food and beverage industry. • David Sherwyn, professor of hospitality human resources and professor of law, is the director of the Cornell Center for Innovative Hospitality Labor & Employment Relations. Sherwyn can discuss issues of union/management relations at this time of crisis, and other issues that have arisen in the hospitality workforce due to the COVID-19. • Linda Canina, professor of finance and director of Cornell’s Center for Hospitality Research, is in day-to-day communications with hospitality leaders in the areas of analytics, operations, performance evaluation, competitive analysis, and valuation, among others.

- 30 -

 




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.34852